These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38051345)

  • 1. Upper and lower limb tremor in Charcot-Marie-Tooth neuropathy type 1A and the implications for standing balance.
    Silsby M; Yiannikas C; Fois AF; Kennerson ML; Kiernan MC; Fung VSC; Vucic S
    J Neurol; 2024 Apr; 271(4):1776-1786. PubMed ID: 38051345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Established and novel measures of upper limb impairment in children with Charcot-Marie-tooth disease type 1A and riboflavin transporter deficiency type 2.
    Cornett KMD; Menezes MP; Bray P; Halaki M; Burns J
    J Peripher Nerv Syst; 2018 Mar; 23(1):29-35. PubMed ID: 29168276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombination hot spot in a 3.2-kb region of the Charcot-Marie-Tooth type 1A repeat sequences: new tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth type 1A. French CMT Collaborative Research Group.
    Lopes J; LeGuern E; Gouider R; Tardieu S; Abbas N; Birouk N; Gugenheim M; Bouche P; Agid Y; Brice A
    Am J Hum Genet; 1996 Jun; 58(6):1223-30. PubMed ID: 8651299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tripod pinch strength and thumb opposition are the major determinants of manual dexterity in Charcot-Marie-Tooth disease type 1A.
    Videler AJ; Beelen A; van Schaik IN; Verhamme C; van den Berg LH; de Visser M; Nollet F
    J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):828-33. PubMed ID: 20562406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Afferent control of walking: are there distinct deficits associated to loss of fibres of different diameter?
    Nardone A; Corna S; Turcato AM; Schieppati M
    Clin Neurophysiol; 2014 Feb; 125(2):327-35. PubMed ID: 23948160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot-Marie-Tooth disease type 1A.
    Dinesh K; White N; Baker L; Sowden JE; Behrens-Spraggins S; Wood E; Charles J; Herrmann DN; Sharma G; Eichinger K
    J Peripher Nerv Syst; 2023 Sep; 28(3):368-381. PubMed ID: 37209301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in hereditary neuropathy with liability to pressure palsies is as impaired as in Charcot-Marie-Tooth disease type 1A.
    Bjelica B; Peric S; Bozovic I; Jankovic M; Brankovic M; Palibrk A; Rakocevic Stojanovic V
    Acta Neurol Belg; 2021 Dec; 121(6):1481-1486. PubMed ID: 32335868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inflammatory demyelinating polyradiculoneuropathy-associated tremor: Phenotype and pathogenesis.
    Silsby M; Fois AF; Yiannikas C; Ng K; Kiernan MC; Fung VSC; Vucic S
    Eur J Neurol; 2023 Apr; 30(4):1059-1068. PubMed ID: 36692234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter Validation of the Charcot-Marie-Tooth Functional Outcome Measure.
    Mandarakas MR; Eichinger KJ; Bray P; Cornett KMD; Shy ME; Reilly MM; Ramdharry GM; Scherer SS; Pareyson D; Estilow T; McKay MJ; ; Herrmann DN; Burns J
    Neurology; 2024 Feb; 102(3):e207963. PubMed ID: 38237108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene.
    Taioli F; Cabrini I; Cavallaro T; Acler M; Fabrizi GM
    Brain; 2011 Feb; 134(Pt 2):608-17. PubMed ID: 21252112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical and Mental Aspects of Quality of Life in Patients With Charcot-Marie-Tooth Disease Type 1A.
    Ivanovic V; Bjelica B; Palibrk A; Brankovic M; Bozovic I; Basta I; Savic A; Stojanovic VR; Kacar A
    Front Neurol; 2022; 13():852150. PubMed ID: 35370888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of sciatic nerve changes in Charcot-Marie-Tooth type 1A patients using magnetic resonance neurography.
    Fortanier E; Ogier AC; Delmont E; Lefebvre MN; Viout P; Guye M; Bendahan D; Attarian S
    Eur J Neurol; 2020 Aug; 27(8):1382-1389. PubMed ID: 32391944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allele-specific all-or-none PCR product diagnostic strategy for Charcot-Marie-Tooth 1A and hereditary neuropathy with liability to pressure palsies.
    Lin KP; Chou CH; Lee HY; Soong BW
    J Chin Med Assoc; 2006 Feb; 69(2):68-73. PubMed ID: 16570573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Employment status of patients with Charcot-Marie-Tooth type 1A.
    Bjelica B; Brankovic M; Bozovic I; Palibrk A; Kacar A; Rakocevic-Stojanovic V
    Acta Neurol Belg; 2022 Jun; 122(3):641-646. PubMed ID: 33491123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor performance deterioration accelerates after 50 years of age in Charcot-Marie-Tooth type 1A patients.
    Tozza S; Bruzzese D; Pisciotta C; Iodice R; Esposito M; Dubbioso R; Ruggiero L; Topa A; Spina E; Santoro L; Manganelli F
    Eur J Neurol; 2018 Feb; 25(2):301-306. PubMed ID: 29053907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of comorbidities on the phenotype of patients affected by Charcot-Marie-Tooth neuropathy type 1A.
    Ursino G; Alberti MA; Grandis M; Reni L; Pareyson D; Bellone E; Gemelli C; Sabatelli M; Pisciotta C; Luigetti M; Santoro L; Massollo L; Schenone A
    Neuromuscul Disord; 2013 Nov; 23(11):902-6. PubMed ID: 23891256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charcot-Marie-Tooth disease type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP): reliable detection of the CMT1A duplication and HNPP deletion using 8 microsatellite markers in 2 multiplex PCRs.
    Seeman P; Mazanec R; Zidar J; Hrusáková S; Ctvrtecková M; Rautenstrauss B
    Int J Mol Med; 2000 Oct; 6(4):421-6. PubMed ID: 10998431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High glucose level as a modifier factor in CMT1A patients.
    Secchin JB; Leal RCC; Lourenço CM; Marques VD; Nogueira PTL; Santos ACJ; Tomaselli PJ; Marques W
    J Peripher Nerv Syst; 2020 Jun; 25(2):132-137. PubMed ID: 32347995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic spectrum of Charcot-Marie-Tooth disease due to LITAF/SIMPLE mutations: a study of 18 patients.
    Guimarães-Costa R; Iancu Ferfoglia R; Leonard-Louis S; Ziegler F; Magy L; Fournier E; Dubourg O; Bouche P; Maisonobe T; Lacour A; Moerman A; Latour P; Stojkovic T
    Eur J Neurol; 2017 Mar; 24(3):530-538. PubMed ID: 28211240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.